Figure S2 from Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer
Year: 2023
Type: other
Abstract: Figure S2. C57BL/6 mice after 67/5Gy administered in 15 fractions over 19 days. Survival analysis begins the day after RT is completed. No observable toxicity was seen in the first ten days and the first death was at Day 29 in the VEH + RT group. No differences were observed between the two survival curves (Log rank P=0.54.)
Authors: Tara N. Fujimoto, Lauren E. Colbert, Yanqing Huang, Jessica M. Molkentine, Amit Deorukhkar, Laura Baseler, Marimar de la Cruz Bonilla, Meifang Yu, Daniel Lin, Sonal Gupta, Peter K. Cabeceiras, Charles V. Kingsley, Ramesh C. Tailor, Gabriel O. Sawakuchi, Eugene J. Koay, Helen Piwnica-Worms, Anirban Maitra, Cullen M. Taniguchi
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362423136